Assessing cardiac risk
Cardiovascular risk calculators can play a crucial role in prevention and treatment of CVD.
Assessing overall cardiovascular risk is now the cornerstone of primary prevention.
Whether a patient needs statin therapy is a decision that should be made only after the clinician has calculated the patient's risk of developing cardiovascular disease within the next five years.
But which cardiovascular risk calculator should be used? And which risk factors should be considered in that calculation?
In Australia, we have the Australian National Vascular Disease Prevention Alliance (NVDPA) CVD risk calculator.
This tool not only determines a patient's risk of developing heart disease, but can also guide intensity of lipid therapy and provide targets for treatment.
The following case demonstrates the practical application of this risk assessment tool.